Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Elyse Love

Dermatology New York, NY Medical Doctor

NPI 1891174603 CMS profile 7233450

130 E 18Th St, New York, NY 10003

Open in the dashboard

General payments

$73,447

474 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Elyse Love of New York, NY is reported in the CMS Open Payments database as having received $73,447 across 474 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $9,966 71
2024 General $26,669 96
2023 General $6,236 66
2022 General $25,717 98
2021 General $3,712 89
2020 General $1,147 54

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Elyse Love
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to Elyse Love were reported at $9,966. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year Elyse Love Dermatology median Middle half National median
2019 $0 $454 $129–$1,240 $163
2020 $1,147 $235 $81–$756 $114
2021 $3,712 $377 $108–$1,108 $132
2022 $25,717 $514 $143–$1,391 $149
2023 $6,236 $607 $159–$1,674 $160
2024 $26,669 $751 $204–$1,903 $164
2025 $9,966 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. AbbVie, Inc. $32,327 84 payments
  2. Allergan Inc. $24,035 23 payments
  3. Galderma Laboratories, L.P. $8,158 41 payments
  4. VYNE Pharmaceuticals Inc. $1,590 8 payments
  5. Sun Pharmaceutical Industries Inc. $1,144 47 payments
  6. Janssen Biotech, Inc. $1,015 45 payments
  7. Ortho Dermatologics, a division of Bausch Health US, LLC $720 34 payments
  8. Novartis Pharmaceuticals Corporation $491 24 payments
  9. LEO Pharma Inc. $404 18 payments
  10. Amgen Inc. $388 17 payments
  11. Other $3,175 133 payments

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Consulting Fee $49,067 7 payments
  2. Food and Beverage $11,153 445 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $7,000 2 payments
  4. Travel and Lodging $4,649 16 payments
  5. Honoraria $1,400 1 payment
  6. Education $179 3 payments
Products named General payments · program years 2020–2025
  1. BOTOX $19,484 23 payments
  2. SKYRIZI $12,737 36 payments
  3. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastic Surgery $12,388 11 payments
  4. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastics $10,774 7 payments
  5. AMZEEQ $1,590 8 payments
  6. ZILXI $1,464 2 payments
  7. Winlevi $908 36 payments
  8. TREMFYA $866 37 payments
  9. RINVOQ $770 19 payments
  10. Absorica LD $704 29 payments
  11. Other $8,915 401 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

474 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record